<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">952434</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2022.952434</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The effect of age on the clinical characteristics and innate immune cell function in the patients with abdominal sepsis</article-title>
<alt-title alt-title-type="left-running-head">Lu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2022.952434">10.3389/fphys.2022.952434</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Jiaqi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jingyuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1286611/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Liuluan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1115615/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yue</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Ang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1025999/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Critical Care Medicine</institution>, <institution>Beijing Ditan Hospital</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Beijing Key Laboratory of Emerging Infectious Diseases</institution>, <institution>Institute of Infectious Diseases</institution>, <institution>Beijing Ditan Hospital</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Beijing Institute of Infectious Diseases</institution>, <institution>Beijing Ditan Hospital</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>National Center of Integrative Medicine</institution>, <institution>Beijing Ditan Hospital</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/12341/overview">John D. Imig</ext-link>, Medical College of Wisconsin, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1735602/overview">Daniel Prantner</ext-link>, University of Maryland, Baltimore, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/523585/overview">Vijay Kumar</ext-link>, Louisiana State University, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Ang Li, <email>liang@ccmu.edu.cn</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Cell Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>952434</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>05</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>09</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Lu, Liu, Zhu, Zhang and Li.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Lu, Liu, Zhu, Zhang and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Sepsis is a life-threatening dysregulated host response to infection that compromises organ health, and abdominal sepsis is a commonly presenting critical illness in intensive care units (ICU). In this study, we investigate the effect of age on clinical sepsis characteristics and innate immune cells (neutrophils and monocytes) functionality in abdominal sepsis patients. We recruited 32 patients with abdominal sepsis from the Beijing Ditan Hospital&#x2019;s ICU from February 2021 to September 2021, and selected 18 healthy volunteers that were age- and sex-matched as controls for a prospective cohort study. Elderly abdominal sepsis patients (age &#x3e;65&#xa0;years) had the following altered characteristics compared to nonelderly patient controls: lower mean arterial pressure, monocytes percentage, and red blood cell volume distribution width (<italic>p</italic> &#x3c; 0.05); higher neutrophils percentage and neutrophils-to-lymphocytes ratio (<italic>p</italic> &#x3c; 0.05); significantly increased monocyte-produced reactive oxygen (<italic>p</italic> &#x3c; 0.05); increases neutrophilic secretion of TNF-&#x3b1;, as well as lower monocytic secretion of TNF-&#x3b1; (<italic>p</italic> &#x3c; 0.05); higher neutrophil percentage (which was significantly higher in peripheral blood than monocyte percentage). Elderly patients also had significantly increased phagocytic activity in their neutrophils and monocytes (<italic>p</italic> &#x3c; 0.05), significantly reduced neutrophils-produced reactive oxygen (<italic>p</italic> &#x3c; 0.001), and significantly increased TNF-&#x3b1; secretion by monocytes and neutrophils (<italic>p</italic> &#x3c; 0.05). We found that elderly patients have decreased immune cell function and increased release of cytokines compared to younger patients, suggesting individualized treatment plans targeting the elderly septic microenvironment could help prevent organ failure in elderly septic patients and improves patient survival.</p>
</abstract>
<kwd-group>
<kwd>sepsis</kwd>
<kwd>abdominal infection</kwd>
<kwd>age</kwd>
<kwd>clinical features</kwd>
<kwd>innate immunity</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>As people age, their ability to host a dynamic and effective immune response is dampened, increasing the odds of developing opportunistic and pathogenic bacterial infections associated with poor outcomes (<xref ref-type="bibr" rid="B13">Girard et al., 2005</xref>). Treatment of infection in elderly patients is often delayed due to their atypical symptom presentation, further worsening their prognosis. In the United States, the elderly population (65 &#x2b; years of age) accounts for 58%&#x2013;65% of sepsis cases (<xref ref-type="bibr" rid="B8">Dombrovskiy et al., 2007</xref>). Over time, the elderly population has steadily increased and the medical expenditure associated with elderly sepsis treatment follows a similar trend (<xref ref-type="bibr" rid="B33">Starr and Saito, 2014</xref>). Elderly patients are also more likely to experience early death due to various other factors, such as underlying organ dysfunction and compromised immunity, and even survivors require more clinical care and long-term organ function support. Elderly sepsis patients have a high rate of complications and poor long-term survival rate compared to younger patients (<xref ref-type="bibr" rid="B3">Carbajal-Guerrero et al., 2014</xref>). Intra-abdominal infection (IAI) is a common disease in the intensive care units (ICU), which can occur secondary to cirrhosis, gastrointestinal perforation, necrosis and gangrene, suppurative appendicitis, appendiceal perforation, intestinal obstruction, and intestinal necrosis. Severe IAI can easily trigger a systemic inflammatory response due to the entry of a large number of bacteria over a short period of time (<xref ref-type="bibr" rid="B18">Mazuski et al., 2017</xref>). IAI is a major contributing factor to the development of sepsis in ICU patients and is also associated with rapid disease progression. Patient outcomes can be improved by noticing important IAI-related factors in sepsis, avoid the increased possibility of sepsis, and finally improve the quality of life of patients with IAI-related sepsis in ICU.</p>
<p>As the immune system ages it begins to undergo immunosenescence. This causes a variety of physiological, biochemical, and hormonal changes that cause an imbalance within the immune system. This imbalance is responsible for the increased susceptibility of elderly patients to infection, reduced efficacy of vaccination, and a chronic low-level inflammatory state (<xref ref-type="bibr" rid="B10">F&#xfc;l&#xf6;p et al., 2016</xref>; <xref ref-type="bibr" rid="B28">Sadighi Akha, 2018</xref>). Elderly patients with additional pre-existing conditions, such as diabetes, malignant tumors, heart, kidney, or liver diseases, are more likely to develop sepsis once abdominal infection occurs (<xref ref-type="bibr" rid="B5">Chen et al., 2018</xref>). The immunosuppressive state induced by intra-abdominal sepsis is confirmed in a growing number of experimental studies (<xref ref-type="bibr" rid="B37">Vincent et al., 2020</xref>) and in clinical case studies on sepsis patients. Neutrophils and monocytes are key effector cells of the innate immune response and play an important role in host defense. These cells can recognize and phagocytose pathogens, produce inflammatory mediators, and initiate other immunological mechanisms, such as the recruitment of polymorphonuclear cells from peripheral blood to the site of infection, that ultimately lead to resolution of infection. The main objective of this prospective study was to investigate the effect of age on clinical sepsis characteristics as well as neutrophil and monocyte function in abdominal sepsis patients. Accurate understanding of changes in clinical characteristics and immune function in elderly patients with abdominal sepsis can help improve prognosis by facilitating timely diagnosis and selection of the best treatment.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Study subjects and grouping</title>
<p>In this study, we included 32 abdominal infection patients with sepsis that were recruited from the Beijing Ditan Hospital ICU between February 2021 and September 2021. These patients were divided into two groups, the elderly group (&#x2265;65&#xa0;years, 14 patients) and the non-elderly group (&#x3c;65&#xa0;years, 18 patients), based on the reported age threshold (<xref ref-type="bibr" rid="B23">Narci et al., 2009</xref>) for epidemiological analysis. We compared the neutrophil and monocyte phagocytic function, neutrophil and monocyte respiratory burst function, neutrophil and monocyte tumor necrosis factor- alpha (TNF-&#x3b1;) release function, and neutrophil and monocyte phenotypes between patients and healthy controls (<italic>n</italic> &#x3d; 18). We also compared the clinical features, neutrophil and monocyte functions, phenotype, and outcome measures of patients on the first day of diagnosis with abdominal sepsis between the elderly group and the non-elderly group. Patients were tracked until December 2021 to record their infectious events, the development of organ failure, 90-day survival, hospitalization, and ICU stay.</p>
</sec>
<sec id="s2-2">
<title>Inclusion criteria</title>
<p>In this study we included patients between the ages of 18 and 80 who were diagnosed with abdominal sepsis during hospitalization. Diagnostic criteria for abdominal sepsis were: 1) deemed septic by the Sequential Organ Failure Assessment (SOFA) score where sepsis is defined by a score increase of 2 or equal to 2. For screening purposes, rapid SOFA scores based on three criteria for neurologic (Glasgow Coma Scale &#x3c;15), cardiovascular (systolic blood pressure &#x3c;100&#xa0;mmHg), and respiratory (respiratory rate &#x3e;22/min) dysfunction are available clinically identified patients at high risk of sepsis. The diagnostic criteria for septic shock were that vasopressor drug therapy is initiationly and continuously needed to maintain a mean arterial pressure &#x3e;65&#xa0;mmHg or a serum lactate level &#x3e;2&#xa0;mmol/L, and that the infection site is in the abdominal cavity. 2) There are at least two ways to diagnose abdominal infection: such as history taking, physical examination, laboratory examination, imaging examination and abdominal paracentesis. History taking and physical examination can help diagnose patients with suspected IAI, and laboratory tests can further identify the degree of disease progression. Among them, symptoms and signs such as abdominal pain, rebound pain, cessation of flatus and defecation by anus, and fever all have a strong suggestive effect on abdominal infection, while white blood cell (WBC) count, C-reactive protein (CRP), and procalcitonin (PCT) can predict the degree of infection progression. Imaging examination and paracentesis is important for the localization of the source of infection, the severity of the lesion, and the selection of subsequent treatment measures. 3) Healthy, age- and sex-matched, non-smoking volunteers with no history of liver disease served as healthy controls (HC). HC alcohol intake was &#x3c;20&#xa0;g/day and volunteers did not drink alcohol or exercise excessively within 24&#xa0;h before blood sampling. 4) The above tests were carried out with the informed consent of the patients and their families and were approved by the Medical Ethics Committee.</p>
</sec>
<sec id="s2-3">
<title>Exclusion criteria</title>
<p>The following patients were excluded from this study: 1) patients with incomplete clinical data; 2) patients who took antibiotics for at least 5&#xa0;days due to suspected infection in the past 30&#xa0;days; 3) patients with a history of any immunodeficiency including malignancy or human immunodeficiency virus (HIV); 4) patients treated with immunosuppressive agents (prednisolone, azathioprine); 5) patients with successful resuscitation after sudden cardiac arrest; and 6) pregnant women.</p>
</sec>
<sec id="s2-4">
<title>Ethics, informed consent, and data collection</title>
<p>This study was approved by Committee of Ethics at Beijing Ditan Hospital, Capital Medical University [Department of medical ethics; Beijing Ditan Hospital (2021)-005]. Blood samples, clinical, biochemical data, and physiological data of patients were collected after obtaining fully informed consent. The blood samples of the HC group were from the Health Examination Center of Beijing Ditan Hospital.</p>
</sec>
<sec id="s2-5">
<title>Flow cytometry</title>
<p>We collected 4&#xa0;ml of peripheral blood from sepsis patients and HC, added it into Ethylene Diamine Tetraacetic Acid (EDTA) anticoagulant tubes and immediately pre-cooled samples to 0&#xb0;C&#x2013;4&#xb0;C. We performed the neutrophil and monocyte function analysis within 2&#xa0;h of blood being drawn. The solution was aspirated into a centrifuge tube and the erythrocytes were lysed with ammonium chloride lysis buffer (BioLegend, United States) and washed with phosphate buffered saline (PBS) (Corning, United States). Single cells were obtained by adding 10% fetal bovine serum (Gibco, United States) and Roswell Park Memorial Institute (RPMI) 1640 medium containing 1% penicillin and streptomycin (Corning, United States) for <italic>in vitro</italic> culture and incubated in a carbon dioxide incubator for 30&#xa0;min. Flow cytometry was performed on cells with the following antibodies: PE anti-CD16 (BioLegend), APC anti-CD14 (BioLegend, United States), PerCP anti-CD45 (BioLegend, United States), FITC anti-CD16 (BioLegend, United States), BV421 anti-TNF-&#x3b1; (BioLegend, United States). Latex Beads (Carboxylate-modified, Yellow-green, Sigma) were used for cellular phagocytic function analysis. The respiratory burst of cells was detected with 2,7-dichlorofluorescein diacetate (DCFH-DA. Sigma). Samples were processed through a BD FACSCanto flow cytometer and analyzed. After obtaining 50,000&#x2013;100,000 cells per sample, cells were selectively gated by forward scattering versus side scatter dot plots. Flowjo V10 software was used to analyze the flow cytometry data, and GraphPad Prism7 was used to perform the graphing and statistical analysis.</p>
</sec>
<sec id="s2-6">
<title>Phagocytic test</title>
<p>Yellow-green-labeled Latex beads were added to the peripheral blood single cell suspension, incubated in a carbon dioxide incubator at 37&#xb0;C for 3&#xa0;h, placed on ice for 10&#xa0;min to stop phagocytosis, and then washed twice with PBS buffer. Next, the corresponding cell surface fluorescent antibody combination was added (CD16-PE/CD14-APC/CD45-PerCP staining) and allowed to incubate at room temperature for 15&#xa0;min in the dark. PBS buffer was added after the incubation period for washing. The ratio of Beads&#x2b; cells in neutrophils and monocytes was detected and analyzed by flow cytometer to determine the phagocytic function.</p>
</sec>
<sec id="s2-7">
<title>Determination of respiratory burst</title>
<p>Peripheral blood single-cell suspensions from patients and age-matched healthy controls were simultaneously assayed with 0.5&#xa0;mg/ml DCFH-DA. The peripheral blood single cell suspension was incubated in a carbon dioxide incubator at 37&#xb0;C for 15&#xa0;min, fixed with 4% paraformaldehyde for 10&#xa0;min, washed twice with PBS buffer, and then received a combination of neutrophil fluorescent antibodies (CD16-PE/CD14-APC/CD45-PerCP staining), Samples were incubated at room temperature for 15&#xa0;min in the dark, washed with PBS buffer, and then run through the flow cytometer to analyze the proportion of DCFH&#x2b; cells in neutrophils and monocytes, and measure the generation of reactive oxygen species (ROS) in that percentage of cells.</p>
</sec>
<sec id="s2-8">
<title>Determination of intracellular factor tumor necrosis factor- alpha</title>
<p>Golgi plug (Thermal Fisher, United States) was added to the peripheral blood single-cell suspension to block the secretion of cytokines. Golgi plug was incubated with cells at 37&#xb0;C in a carbon dioxide incubator for 3&#xa0;h, and the neutrophil fluorescent antibody combination (CD16-FITC/CD14-APC/CD45-PerCP staining) was added, incubated at room temperature for 15&#xa0;min in the dark, and then washed with PBS buffer. Next, we added the intracellular fluorescent staining kit Fix-Perm (BD bioscience, United States) membrane breaking agent, incubated at 4&#xb0;C for 20&#xa0;min in the dark, used Perm Wash (Becton Dickinson, United States) to rinse twice, added intracellular protein fluorescent antibody TNF-&#x3b1;-BV421, incubated at 4&#xb0;C in the dark for 30&#xa0;min, and, lastly, washed twice with Perm Wash. We used flow cytometry to analyze the ratio of TNF-&#x3b1;&#x2b; in neutrophils and monocytes, and measure the function of producing TNF-&#x3b1;.</p>
</sec>
<sec id="s2-9">
<title>Statistical analysis</title>
<p>The data of subjects with normal distribution were expressed in the form of mean &#xb1; standard deviation. The difference in unpaired data between two groups was analyzed by independent sample <italic>t</italic>-test, and the paired data was analyzed by paired sample <italic>t</italic>-test, Data for more than two groups were analyzed by one-way ANOVA. Data that was not normally distributed was expressed by median and interquartile range. The unpaired data between two groups was analyzed by Mann-Whitney test, and the paired data was analyzed by Wilcoxon matched-pairs signed rank test. For all data, <italic>p</italic> &#x3c; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Baseline demographic characteristics and clinical parameters of patients in different age groups</title>
<p>Among the 32 recruited patients, 14 (43.8%) were elderly and 18 (56.2%) were non-elderly, with no significant difference in gender between these two groups (<italic>p</italic> &#x3d; 0.458). As shown in <xref ref-type="table" rid="T1">Table1</xref>, 64.3% (9/14) of the elderly patients but only 44.4% (8/18) of the non-elderly patients had underlying diseases (<italic>p</italic> &#x3d; 0.308). Septic shock was more common in the elderly group (78.6%) than in the non-elderly group (50%), but no significant difference was detected for this trend (<italic>p</italic> &#x3d; 0.098). By comparing the basic vital signs of patients on the first day of diagnosis, it was found that the mean arterial pressure distribution of the elderly group and the non-elderly group was 60 (56&#x2013;70) mmHg and 73 (64&#x2013;81) mmHg, respectively, which was significantly different (<italic>p</italic> &#x3d; 0.020). In addition, the comparison of routine blood parameters between the two groups demonstrated that the percentage of neutrophils in the elderly group on the first day [88.0% (83.1%&#x2013;91.7%)] were significantly higher than those in the non-elderly group [83.7% (73.3%)]-87.1%)] (<italic>p</italic> &#x3d; 0.017). The monocytes percentage [5.3% (3.7%&#x2013;7.1%)], however, was significantly lower in the elderly group when compared to the non-elderly group [8.3% (5.0%&#x2013;13.2%)] (<italic>p</italic> &#x3d; 0.040). The neutrophil to lymphocyte ratio (NLR), derived from complete blood cell count, has been shown to be a widely used non-specific inflammatory marker, and recent studies have found that the addition of platelet count to this ratio, (the neutrophil to lymphocyte and platelet ratio, NLPR), is expected to further improve its clinical value. In this study, our results showed that the NLRs of elderly patients [14.07 (9.48&#x2013;27.40)] were significantly higher than those of non-elderly patients [11.38 (5.08&#x2013;15.18)] (<italic>p</italic> &#x3d; 0.003). Meanwhile, the NLPRs of patients in the elderly group [14.59 (8.70&#x2013;24.95)] were also higher than those of patients in the non-elderly group [10.59 (7.16&#x2013;16.66)], but the difference was not statistically significant (<italic>p</italic> &#x3d; 0.067). In addition, the red blood cell volume distribution widths in the elderly group [15.4% (13.1%&#x2013;17.6%)] were significantly lower than those in the non-elderly group [18.2% (14.3%&#x2013;22.3%) (<italic>p</italic> &#x3d; 0.044)].</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Basic clinical characteristics of patients with abdominal sepsis in different age groups.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">&#xa0;</th>
<th align="left"/>
<th align="left">Total (<italic>n</italic> &#x3d; 32)</th>
<th align="left">Group A (&#x2265;65; <italic>n</italic> &#x3d; 14)&#xa0;</th>
<th align="left">Group B (&#x3c;65; <italic>n</italic> &#x3d; 18)&#xa0;</th>
<th align="left">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Demographic characteristics</td>
<td align="left">Male (%)</td>
<td align="left">21 (65.6)</td>
<td align="left">9 (64.2)&#xa0;</td>
<td align="left">12 (66.7)</td>
<td align="left">0.458</td>
</tr>
<tr>
<td rowspan="5" align="left">Basic disease</td>
<td align="left">Basic diseases (%)</td>
<td align="left">17 (53.1)</td>
<td align="left">9 (64.3)</td>
<td align="left">8 (44.4)</td>
<td align="left">0.308</td>
</tr>
<tr>
<td align="left">Hypertension (%)&#xa0;</td>
<td align="left">13 (40.6)</td>
<td align="left">9 (64.3)&#xa0;</td>
<td align="left">4 (22.2)&#xa0;</td>
<td align="left">0.149</td>
</tr>
<tr>
<td align="left">Diabetes (%)&#xa0;</td>
<td align="left">7 (21.9)</td>
<td align="left">4 (28.6)&#xa0;</td>
<td align="left">3 (16.7)&#xa0;</td>
<td align="left">0.669</td>
</tr>
<tr>
<td align="left">CHD (%)&#xa0;</td>
<td align="left">4 (12.5)</td>
<td align="left">3 (21.4)&#xa0;</td>
<td align="left">1 (5.6)&#xa0;</td>
<td align="left">0.295</td>
</tr>
<tr>
<td align="left">CRF(%)&#xa0;</td>
<td align="left">6 (18.8)</td>
<td align="left">4 (28.6)&#xa0;</td>
<td align="left">2 (11.1)&#xa0;</td>
<td align="left">0.365</td>
</tr>
<tr>
<td align="left">Operation</td>
<td align="left">Operation (%)&#xa0;</td>
<td align="left">4 (12.5)</td>
<td align="left">2 (14.3)&#xa0;</td>
<td align="left">2 (11.1)&#xa0;</td>
<td align="left">0.788</td>
</tr>
<tr>
<td align="left">Septic shock</td>
<td align="left">Shock (%)</td>
<td align="left">20 (62.5)</td>
<td align="left">11 (78.6)</td>
<td align="left">9 (50.0)</td>
<td align="left">0.098</td>
</tr>
<tr>
<td align="left">SOFA score</td>
<td align="left">SOFA</td>
<td align="left">6 (5&#x2013;8)</td>
<td align="left">6 (4&#x2013;8)</td>
<td align="left">6 (5&#x2013;9)</td>
<td align="left">0.283</td>
</tr>
<tr>
<td rowspan="5" align="left">Basic vital signs</td>
<td align="left">Temperature (&#xb0;C)</td>
<td align="left">37.5 &#xb1; 0.8</td>
<td align="left">37.3 &#xb1; 0.8</td>
<td align="left">37.7 &#xb1; 0.7</td>
<td align="left">0.106</td>
</tr>
<tr>
<td align="left">HR (per minute)&#xa0;</td>
<td align="left">89 &#xb1; 17&#xa0;</td>
<td align="left">85 &#xb1; 17&#xa0;</td>
<td align="left">93 &#xb1; 16&#xa0;</td>
<td align="left">0.204</td>
</tr>
<tr>
<td align="left">MAP (mmHg)</td>
<td align="left">67 (60&#x2013;77)</td>
<td align="left">60 (56&#x2013;70)</td>
<td align="left">73 (64&#x2013;81)</td>
<td align="left">0.020</td>
</tr>
<tr>
<td align="left">RR (per minute)&#xa0;</td>
<td align="left">17 (16&#x2013;20)</td>
<td align="left">18 (17&#x2013;21)</td>
<td align="left">17 (16&#x2013;19)</td>
<td align="left">0.210</td>
</tr>
<tr>
<td align="left">SPO<sub>2</sub>(%)</td>
<td align="left">97 (95&#x2013;99)</td>
<td align="left">97 (95&#x2013;98)</td>
<td align="left">98 (96&#x2013;99)</td>
<td align="left">0.465</td>
</tr>
<tr>
<td rowspan="6" align="left">Internal environment</td>
<td align="left">PH</td>
<td align="left">7.45 &#xb1; 0.08</td>
<td align="left">7.44 &#xb1; 0.08</td>
<td align="left">7.47 &#xb1; 0.08</td>
<td align="left">0.287</td>
</tr>
<tr>
<td align="left">PCO<sub>2</sub>(mmHg)</td>
<td align="left">35 (28&#x2013;38)</td>
<td align="left">36 (29&#x2013;41)</td>
<td align="left">34 (28&#x2013;37)</td>
<td align="left">0.262</td>
</tr>
<tr>
<td align="left">PO<sub>2</sub>(mmHg)</td>
<td align="left">105 &#xb1; 26</td>
<td align="left">106 &#xb1; 29</td>
<td align="left">104 &#xb1; 24</td>
<td align="left">0.239</td>
</tr>
<tr>
<td align="left">BE (mmol/L)</td>
<td align="left">0.8 &#xb1; 5.2</td>
<td align="left">0.6 &#xb1; 4.5</td>
<td align="left">1.0 &#xb1; 5.9</td>
<td align="left">0.852</td>
</tr>
<tr>
<td align="left">HCO3<sup>-</sup>(mmol/L)</td>
<td align="left">24.5 &#xb1; 4.8</td>
<td align="left">24.5 &#xb1; 4.1</td>
<td align="left">24.5 &#xb1; 5.5</td>
<td align="left">0.998</td>
</tr>
<tr>
<td align="left">Lactate (mmol/L)</td>
<td align="left">1.5 (1.0&#x2013;2.2)</td>
<td align="left">1.4 (1.0&#x2013;2.1)</td>
<td align="left">1.6 (1.1&#x2013;2.2)</td>
<td align="left">0.676</td>
</tr>
<tr>
<td rowspan="15" align="left">Blood routine index</td>
<td align="left">WBC(10<sup>9</sup>/L)</td>
<td align="left">10.4 (6.8&#x2013;16.7)</td>
<td align="left">11.1 (7.6&#x2013;14.6)</td>
<td align="left">10.1 (6.7&#x2013;18.2)</td>
<td align="left">0.761</td>
</tr>
<tr>
<td align="left">NE (%)</td>
<td align="left">85.7 (78.7&#x2013;89.7)</td>
<td align="left">88.0 (83.1&#x2013;91.7)</td>
<td align="left">83.7 (73.3&#x2013;87.1)</td>
<td align="left">0.017</td>
</tr>
<tr>
<td align="left">NEUT (10<sup>9</sup>/L)</td>
<td align="left">8.7 (5.4&#x2013;14.2)</td>
<td align="left">9.1 (6.9&#x2013;13.0)</td>
<td align="left">7.6 (5.0&#x2013;15.6)</td>
<td align="left">0.470</td>
</tr>
<tr>
<td align="left">LY (%)</td>
<td align="left">7.2 (5.6&#x2013;9.2)</td>
<td align="left">6.2 (3.4&#x2013;8.8)</td>
<td align="left">7.5 (5.7&#x2013;13.8)</td>
<td align="left">0.091</td>
</tr>
<tr>
<td align="left">LYM(10<sup>9</sup>/L)</td>
<td align="left">0.8 (0.4&#x2013;1.2)</td>
<td align="left">0.7 (0.3&#x2013;1.0)</td>
<td align="left">0.9 (0.4&#x2013;1.7)</td>
<td align="left">0.086</td>
</tr>
<tr>
<td align="left">MO(%)</td>
<td align="left">6.2 (4.4&#x2013;10.2)</td>
<td align="left">5.3 (3.7&#x2013;7.1)</td>
<td align="left">8.3 (5.0&#x2013;13.2)</td>
<td align="left">0.040</td>
</tr>
<tr>
<td align="left">MONO(10<sup>9</sup>/L)</td>
<td align="left">0.7 (0.3&#x2013;1.1)</td>
<td align="left">0.5 (0.3&#x2013;1.0)</td>
<td align="left">0.9 (0.3&#x2013;1.5)</td>
<td align="left">0.231</td>
</tr>
<tr>
<td align="left">NLR</td>
<td align="left">12.24 (8.73&#x2013;15.65)</td>
<td align="left">14.07 (9.48&#x2013;27.40)</td>
<td align="left">11.38 (5.08&#x2013;15.18)</td>
<td align="left">0.003</td>
</tr>
<tr>
<td align="left">NLPR</td>
<td align="left">12.65 (7.54&#x2013;21.07)</td>
<td align="left">14.59 (8.70&#x2013;24.95)</td>
<td align="left">10.59 (7.16&#x2013;16.66)</td>
<td align="left">0.067</td>
</tr>
<tr>
<td align="left">Hemoglobin (g/L)</td>
<td align="left">92 &#xb1; 27</td>
<td align="left">94 &#xb1; 23</td>
<td align="left">92 &#xb1; 31</td>
<td align="left">0.836</td>
</tr>
<tr>
<td align="left">HCT (%)</td>
<td align="left">27.4 &#xb1; 7.7</td>
<td align="left">27.7 &#xb1; 6.5</td>
<td align="left">27.1 &#xb1; 8.6</td>
<td align="left">0.837</td>
</tr>
<tr>
<td align="left">MCV(fl)</td>
<td align="left">90 &#xb1; 9</td>
<td align="left">93 &#xb1; 7</td>
<td align="left">88 &#xb1; 10</td>
<td align="left">0.177</td>
</tr>
<tr>
<td align="left">MCH(pg)</td>
<td align="left">30.7 (28.9&#x2013;32.8)</td>
<td align="left">30.9 (29.2&#x2013;32.4)</td>
<td align="left">30.0 (27.9&#x2013;33.0)</td>
<td align="left">0.403</td>
</tr>
<tr>
<td align="left">MCHC(g/l)</td>
<td align="left">337 &#xb1; 17</td>
<td align="left">338 &#xb1; 12</td>
<td align="left">336 &#xb1; 21</td>
<td align="left">0.845</td>
</tr>
<tr>
<td align="left">RDW (%)</td>
<td align="left">16.8 (13.7&#x2013;20.3)</td>
<td align="left">15.4 (13.1&#x2013;17.6)</td>
<td align="left">18.2 (14.3&#x2013;22.3)</td>
<td align="left">0.044</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group B indicates the cohort of patients aged &#x3c;65&#xa0;years. CHD, coronary heart disease; CRF, chronic renal failure; SOFA, sequential organ failure assessment; HR, heart rate; MAP, mean Arterial pressure; RR, respiratory rate; SPO<sub>2</sub>, Arterial oxygen saturation; PH, potential of hydrogen; PCO<sub>2</sub>, partial pressure of carbon dioxide; PO<sub>2</sub>, oxygen partial pressure; BE, base excess; HCO<sub>3</sub>
<sup>&#x2212;</sup>, bicarbonate radical; WBC, white blood cell count; NE, neutrophil percentage; NEUT, neutrophil count; LY, percentage of lymphocytes; LYM, lymphocyte count; MO, monocyte percentage; MONO, monocyte count; NLR, neutrophil to lymphocyte ratio; NLPR, neutrophil to lymphocyte and platelet ratio; HCT, hematokrit; MCV, mean corpuscular volume; MCH, mean hemoglobin; MCHC, mean hemoglobin concentration; RDW, red blood cell distribution width.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The comparison of organ function indicators on the first day of diagnosis of sepsis in the two groups showed that the levels of total bilirubin (liver function indicator) in the non-elderly group were higher than those in the elderly group, which were 60.7 (21.0&#x2013;117.2) mmol/L and 15.5 (9.0&#x2013;32.3) mmol/L, respectively (<italic>p</italic> &#x3d; 0.015). However, the differences in renal function, coagulation function, cardiac function, acid-base electrolyte, and some infection indexes were not found to be statistically significant (<italic>p</italic> &#x3e; 0.05) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Visceral function measures in abdominal sepsis patients of different age groups.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left"/>
<th align="left">Total (<italic>n</italic> &#x3d; 32)</th>
<th align="left">Group a (&#x2265;65; <italic>n</italic> &#x3d; 14)&#xa0;</th>
<th align="left">Group B (&#x3c;65; <italic>n</italic> &#x3d; 18)&#xa0;</th>
<th align="left">
<italic>p&#xa0;</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="8" align="left">Liver function index</td>
<td align="left">TBIL (umol/L)</td>
<td align="left">27.1 (14.0&#x2013;92.7)</td>
<td align="left">15.5 (9.0&#x2013;32.3)&#xa0;</td>
<td align="left">60.7 (21.0&#x2013;117.2)&#xa0;</td>
<td align="left">0.015</td>
</tr>
<tr>
<td align="left">DBIL (umol/L)</td>
<td align="left">15.4 (7.0&#x2013;68.7)</td>
<td align="left">8.0 (6.0&#x2013;17.1)&#xa0;</td>
<td align="left">32.9 (13.3&#x2013;100.1)&#xa0;</td>
<td align="left">0.019</td>
</tr>
<tr>
<td align="left">Albumin (g/L)</td>
<td align="left">33.0 &#xb1; 4.9</td>
<td align="left">34.5 &#xb1; 3.5</td>
<td align="left">31.9 &#xb1; 5.6</td>
<td align="left">0.141</td>
</tr>
<tr>
<td align="left">Cholinesterase (U/L)</td>
<td align="left">2441 (1553&#x2013;3989)</td>
<td align="left">2648 (1864&#x2013;4075)</td>
<td align="left">2364 (1146&#x2013;3749)</td>
<td align="left">0.425</td>
</tr>
<tr>
<td align="left">ALT (U/L)</td>
<td align="left">34.7 (11.0&#x2013;71.7)</td>
<td align="left">22.5 (7.4&#x2013;68.1)&#xa0;</td>
<td align="left">38.0 (11.9&#x2013;108.2)&#xa0;</td>
<td align="left">0.333</td>
</tr>
<tr>
<td align="left">AST (U/L)</td>
<td align="left">41.8 (18.6&#x2013;87.3)</td>
<td align="left">39.3 (16.3&#x2013;68.1)&#xa0;</td>
<td align="left">43.8 (20.5&#x2013;117.1)&#xa0;</td>
<td align="left">0.543</td>
</tr>
<tr>
<td align="left">LDH(U/L)</td>
<td align="left">233.8 (176.6&#x2013;350.0)</td>
<td align="left">233.8 (168.3&#x2013;304.1)&#xa0;</td>
<td align="left">222.4 (159.4&#x2013;438.5)&#xa0;</td>
<td align="left">0.739</td>
</tr>
<tr>
<td align="left">CK(U/L)</td>
<td align="left">59.5 (29.3&#x2013;338.2)</td>
<td align="left">95.2 (36.2&#x2013;749.2)&#xa0;</td>
<td align="left">58.0 (22.9&#x2013;260.1)&#xa0;</td>
<td align="left">0.257</td>
</tr>
<tr>
<td rowspan="9" align="left">Coagulation function index</td>
<td align="left">PLT (10<sup>9</sup>/L)</td>
<td align="left">105 (66&#x2013;158)</td>
<td align="left">140 (75&#x2013;185)&#xa0;</td>
<td align="left">97 (58&#x2013;135)&#xa0;</td>
<td align="left">0.119</td>
</tr>
<tr>
<td align="left">PT(s)</td>
<td align="left">16.5 (13.2&#x2013;22.5)</td>
<td align="left">15.1 (13&#x2013;21.2)&#xa0;</td>
<td align="left">18.2 (13.7&#x2013;23.1)&#xa0;</td>
<td align="left">0.436</td>
</tr>
<tr>
<td align="left">PTA&#xa0;(%)</td>
<td align="left">55 &#xb1; 21</td>
<td align="left">58 &#xb1; 23</td>
<td align="left">52 &#xb1; 19</td>
<td align="left">0.478</td>
</tr>
<tr>
<td align="left">APTT(s)&#xa0;</td>
<td align="left">36.2 (29.2&#x2013;42.3)</td>
<td align="left">33.3 (28.7&#x2013;42.6)&#xa0;</td>
<td align="left">36.4 (31.8&#x2013;43.7)&#xa0;</td>
<td align="left">0.403</td>
</tr>
<tr>
<td align="left">Fib (mg/dl)&#xa0;</td>
<td align="left">279 (150&#x2013;420)</td>
<td align="left">335 (163&#x2013;457)&#xa0;</td>
<td align="left">193 (132&#x2013;338)&#xa0;</td>
<td align="left">0.087</td>
</tr>
<tr>
<td align="left">INR (%)</td>
<td align="left">1.5 (1.2&#x2013;2.0)</td>
<td align="left">1.4 (1.2&#x2013;2.0)&#xa0;</td>
<td align="left">1.7 (1.3&#x2013;2.0)&#xa0;</td>
<td align="left">0.436</td>
</tr>
<tr>
<td align="left">FDP (ug/mL)</td>
<td align="left">11.8 (7.1&#x2013;24.1)</td>
<td align="left">11.4 (8.1&#x2013;16.7)</td>
<td align="left">13.3 (4.9&#x2013;49.1)</td>
<td align="left">0.820</td>
</tr>
<tr>
<td align="left">D - dimer (mg/L)</td>
<td align="left">3.8 (1.9&#x2013;11.5)</td>
<td align="left">3.8 (2.8&#x2013;6.8)</td>
<td align="left">4.3 (1.6&#x2013;18.0)&#xa0;</td>
<td align="left">0.924</td>
</tr>
<tr>
<td align="left">PT(s)</td>
<td align="left">17.6 (14.5&#x2013;19.6)</td>
<td align="left">17.1 (14.2&#x2013;19.3)</td>
<td align="left">18.0 (14.6&#x2013;19.7)</td>
<td align="left">0.648</td>
</tr>
<tr>
<td rowspan="11" align="left">Renal function index</td>
<td align="left">K<sup>&#x2b;</sup>(mmol/L)&#xa0;</td>
<td align="left">3.8 &#xb1; 0.5</td>
<td align="left">4.0 &#xb1; 0.5</td>
<td align="left">141.5 &#xb1; 7.0</td>
<td align="left">0.097</td>
</tr>
<tr>
<td align="left">Na<sup>&#x2b;</sup>(mmol/L)&#xa0;</td>
<td align="left">104.2 &#xb1; 6.1</td>
<td align="left">138.7 &#xb1; 4.3</td>
<td align="left">27.1 &#xb1; 8.6</td>
<td align="left">0.207</td>
</tr>
<tr>
<td align="left">CL<sup>&#x2212;</sup>(mmol/L)</td>
<td align="left">103.5 (100.6&#x2013;107.9)</td>
<td align="left">102.5 (99.7&#x2013;105.8)&#xa0;</td>
<td align="left">104.7 (101.3&#x2013;113.3)&#xa0;</td>
<td align="left">0.210</td>
</tr>
<tr>
<td align="left">Ca<sup>2&#x2b;</sup>(mmol/L)</td>
<td align="left">2.1 &#xb1; 0.2</td>
<td align="left">2.1 &#xb1; 0.2</td>
<td align="left">2.1 &#xb1; 0.2</td>
<td align="left">0.776</td>
</tr>
<tr>
<td align="left">Mg<sup>2&#x2b;</sup>(mmol/L)</td>
<td align="left">1.0 &#xb1; 0.2</td>
<td align="left">1.0 &#xb1; 0.2</td>
<td align="left">0.9 &#xb1; 0.2</td>
<td align="left">0.087</td>
</tr>
<tr>
<td align="left">Carbamide (mmol/L)</td>
<td align="left">9.8 (6.4&#x2013;17.2)</td>
<td align="left">10.0 (5.9&#x2013;14.4)</td>
<td align="left">9.8 (6.5&#x2013;22.4)</td>
<td align="left">0.470</td>
</tr>
<tr>
<td align="left">Creatinine (umol/L)</td>
<td align="left">107.0 (69.9&#x2013;172.6)</td>
<td align="left">120.7 (62.0&#x2013;182.8)</td>
<td align="left">107.0 (70.3&#x2013;171.1)</td>
<td align="left">0.790</td>
</tr>
<tr>
<td align="left">Blood Glucose (mmol/L)</td>
<td align="left">10.5 &#xb1; 3.2</td>
<td align="left">11.4 &#xb1; 3.2</td>
<td align="left">9.7 &#xb1; 3.2</td>
<td align="left">0.148</td>
</tr>
<tr>
<td align="left">AG (mmol/L)</td>
<td align="left">16.6 &#xb1; 4.1</td>
<td align="left">16.6 &#xb1; 3.4</td>
<td align="left">16.6 &#xb1; 4.6</td>
<td align="left">0.988</td>
</tr>
<tr>
<td align="left">Crystalloid Osmotic Pressure</td>
<td align="left">301.9 (294.1&#x2013;310.1)</td>
<td align="left">300.3 (295.1&#x2013;307.8)&#xa0;</td>
<td align="left">304.6 (293.2&#x2013;314.3)&#xa0;</td>
<td align="left">0.382</td>
</tr>
<tr>
<td align="left">GFR (ml/min/1.73&#xa0;m2)</td>
<td align="left">56.7 (30.9&#x2013;98.4)</td>
<td align="left">51.3 (28.4&#x2013;94.5)&#xa0;</td>
<td align="left">56.7 (36.8&#x2013;102.6)&#xa0;</td>
<td align="left">0.518</td>
</tr>
<tr>
<td rowspan="4" align="left">Cardiac function index</td>
<td align="left">BNP(pg/ml)</td>
<td align="left">478.3 (65.3&#x2013;770.9)</td>
<td align="left">250.8 (39.5&#x2013;1104.0)&#xa0;</td>
<td align="left">481.7 (81.2&#x2013;654.8)&#xa0;</td>
<td align="left">0.896</td>
</tr>
<tr>
<td align="left">Myohemoglobin (ng/ml)</td>
<td align="left">126.7 (89.3&#x2013;368.4)</td>
<td align="left">170.3 (88.1&#x2013;373.3)&#xa0;</td>
<td align="left">122.6 (96.3&#x2013;340.1)&#xa0;</td>
<td align="left">0.868</td>
</tr>
<tr>
<td align="left">TNI(ng/mL)</td>
<td align="left">0.038 (0.012&#x2013;0.195)</td>
<td align="left">0.023 (0.012&#x2013;0.076)&#xa0;</td>
<td align="left">0.054 (0.011&#x2013;12.059)&#xa0;</td>
<td align="left">0.984</td>
</tr>
<tr>
<td align="left">CK-MB(ng/mL)&#xa0;</td>
<td align="left">2.1 (0.6&#x2013;8.1)</td>
<td align="left">2.4 (0.9&#x2013;8.1)&#xa0;</td>
<td align="left">1.9 (0.5&#x2013;7.5)&#xa0;</td>
<td align="left">0.510</td>
</tr>
<tr>
<td rowspan="2" align="left">Infection index</td>
<td align="left">PCT (ng/mL)</td>
<td align="left">1.8 (0.5&#x2013;6.2)</td>
<td align="left">1.3 (0.6&#x2013;4.4)</td>
<td align="left">2.5 (0.4&#x2013;6.5)</td>
<td align="left">0.494</td>
</tr>
<tr>
<td align="left">CRP (mg/L)</td>
<td align="left">68.0 (34.1&#x2013;115.6)</td>
<td align="left">82 (40.1&#x2013;118.3)</td>
<td align="left">49.1 (15.6&#x2013;108.2)</td>
<td align="left">0.153</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group B indicates the cohort of patients aged &#x3c;65&#xa0;years. TBIL, total bilirubin; DBIL: direct bilirubin; ALT, alanine transaminase; AST, aspartate Aminotransferase; LDH, lactic dehydrogenase; CK, creatine kinase; PLT, platelet count; PT, prothrombin time; PTA, prothrombin activity; APTT, activated partial thromboplastin time; Fib, Fibrinogen; INR, international normalized ratio; FDP, fibrinogen degradation product; K<sup>&#x2b;</sup>, serum kalium; Na<sup>&#x2b;</sup>, Natriumion; CL<sup>&#x2212;</sup>, chloridion; Ca<sup>2&#x2b;</sup>, Calciumion; Mg<sup>2&#x2b;</sup>, Magnesiumion; AG, anion gap; GFR, glomerular filtration rate; BNP, B Type Natriuretic Peptide; TNI, Hypersensitive Troponin I; CK-MB, Creative kinase Isoenzyme MB; PCT, procalcitonin; CRP, C-reactive protein.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>Phagocytic function of innate immune cells</title>
<p>Neutrophils and monocytes are important components of the innate immune response in sepsis, both of which have phagocytic function. Once phagocytes find and recognize pathogens, phagocytosis will occur, and then phagocytic enzyme activity increases. In order to understand the phagocytic function of patients with abdominal sepsis in different age groups, the phagocytic function of phagocytes collected on the first day of diagnosis of abdominal sepsis was detected by flow cytometry (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>), and compared with that of healthy volunteers (<xref ref-type="fig" rid="F2">Figure 2</xref>). We found that the phagocytic function of both neutrophils and monocytes was elevated in patients with peritoneal sepsis compared to healthy volunteers (<italic>p</italic> &#x3c; 0.001). In terms of neutrophils (<xref ref-type="fig" rid="F2">Figure 2A</xref>), the phagocytic function of elderly abdominal sepsis patients was lower than that of non-elderly patients (<italic>p</italic> &#x3e; 0.05). Similarly, the phagocytic function of monocytes in the elderly group was lower than that of the non-elderly group (<italic>p</italic> &#x3e; 0.05) (<xref ref-type="fig" rid="F2">Figure 2B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Histograms of flow cytometry were applied to represent the functions of the two immune cells. <bold>(A)</bold> Indicates the phagocytic function of neutrophils. <bold>(B)</bold> Indicates monocyte phagocytic function. <bold>(C)</bold> Represents the neutrophil ROS production results. <bold>(D)</bold> Represents monocyte ROS production results. <bold>(E)</bold> Represents neutrophil intracellular TNF- &#x3b1; production proportions. <bold>(F)</bold> Indicates monocytic intracellular TNF- &#x3b1; production proportions. Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group A indicates the cohort of patients aged &#x3c;65&#xa0;years. Tumor Necrosis Factor- alpha, TNF-&#x3b1;; Reactive Oxygen Species, ROS.</p>
</caption>
<graphic xlink:href="fphys-13-952434-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Phagocytosis of neutrophils and monocytes in healthy controls and patients with abdominal sepsis of different age groups. Note: <bold>(A)</bold> Represents the phagocytic function of neutrophils. <bold>(B)</bold> Represents the phagocytic function of monocytes. Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group A indicates the cohort of patients aged &#x3c;65&#xa0;years. We utilize how many of the asterisks indicate the magnitude of the <italic>p</italic>-value. &#x201c;&#x2a;&#x2a;&#x2a;&#x2a;&#x201d; indicates <italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphys-13-952434-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Respiratory burst of innate immune cells</title>
<p>In order to clarify the changes of respiratory burst function of phagocytes and further explore their actual ability to eliminate pathogenic microorganisms, we detected the production of cellular ROS (<xref ref-type="fig" rid="F1">Figures 1C,D</xref>). The production of ROS by neutrophils was significantly reduced in both elderly and non-elderly patients with abdominal sepsis compared with HC group (<xref ref-type="fig" rid="F3">Figure 3A</xref>) (<italic>p</italic> &#x3c; 0.001), but the decrease degree between the elderly group and non-elderly group was not statistically significant (<italic>p</italic> &#x3e; 0.05). As seen from <xref ref-type="fig" rid="F3">Figure 3B</xref>, the monocyte ROS production in elderly patients was significantly higher than that of the non-elderly group (<italic>p</italic> &#x3c; 0.05), and the production of ROS by monocytes in the non-elderly group was higher than healthy volunteers, however the difference was not statistically significant (<italic>p</italic> &#x3e; 0.05). In addition, we employed the mean fluorescence intensity to profile the results of cellular ROS production (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>ROS production by neutrophils and monocytes in healthy controls and patients with abdominal sepsis of different age groups. Note: <bold>(A)</bold> Represents ROS of neutrophils. <bold>(B)</bold> Represents ROS of monocytes. Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group A indicates the cohort of patients aged &#x3c;65&#xa0;years. Reactive Oxygen Species, ROS. We utilize how many of the asterisks indicate the magnitude of the <italic>p</italic>-value. &#x201c;&#x2a;&#x201d; indicates <italic>p</italic> &#x3c; 0.05. &#x201c;&#x2a;&#x2a;&#x2a;&#x2a;&#x201d; indicates <italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphys-13-952434-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Description of ROS generation results by mean fluorescence intensity along with comparison. Note: <bold>(A)</bold> Represents the mean fluorescence intensity of the results of ROS production by neutrophils. <bold>(B)</bold> Represents the mean fluorescence intensity of the results for ROS production by monocytes. Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group A indicates the cohort of patients aged &#x3c;65&#xa0;years. Reactive Oxygen Species, ROS. We utilize how many of the asterisks indicate the magnitude of the <italic>p</italic>-value. &#x201c;&#x2a;&#x2a;&#x2a;&#x2a;&#x201d; indicates <italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphys-13-952434-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Intracellular tumor necrosis factor- alpha release from innate immune cells</title>
<p>Neutrophils and monocytes are the main effector cells of the innate immune system. During infection, neutrophils eliminate pathogens mainly through phagocytosis and the release of ROS, but their ability to release inflammatory factors is weaker than monocytes. Here we further explored the effect of age on the intracellular TNF-&#x3b1; secretion capacity of neutrophils and monocytes (<xref ref-type="fig" rid="F1">Figures 1E,F</xref>). The positive proportion of monocytes and neutrophils capable of secreting TNF-&#x3b1; was significantly lower in healthy volunteers compared with patients with abdominal sepsis (<italic>p</italic> &#x3c; 0.05) (<xref ref-type="fig" rid="F5">Figure 5</xref>). Concerning age, the proportion of neutrophils able to secrete TNF was significantly higher in elderly patients with abdominal sepsis than in nonelderly patients (<xref ref-type="fig" rid="F5">Figure 5A</xref>). However, previous clinical routine blood data showed that the percentage of neutrophils in peripheral blood was significantly higher than that of monocytes, and the percentage of neutrophils in elderly patients was higher, (<italic>p</italic> &#x3c; 0.05) (<xref ref-type="table" rid="T1">Table 1</xref>). The percentage of monocytes in the non-elderly group was significantly higher than that in the elderly group.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>TNF-&#x3b1; production from neutrophils and monocytes in healthy controls and patients with abdominal sepsis of different age groups. Note: <bold>(A)</bold> represents TNF- &#x3b1; secretory <bold>function of</bold> neutrophils. <bold>(B)</bold> represents TNF- &#x3b1; secretory <bold>function of</bold> monocytes. Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group A indicates the cohort of patients aged &#x3c;65&#xa0;years. Tumor Necrosis Factor- alpha, TNF-&#x3b1;. We utilize how many of the asterisks indicate the magnitude of the <italic>p</italic>-value. &#x201c;&#x2a;&#x201d; indicates <italic>p</italic> &#x3c; 0.05. &#x201c;&#x2a;&#x2a;&#x201d; indicates <italic>p</italic> &#x3c; 0.01. &#x201c;&#x2a;&#x2a;&#x2a;&#x2a;&#x201d; indicates <italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphys-13-952434-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Clinical outcomes associated with different age groups</title>
<p>As shown in <xref ref-type="table" rid="T3">Table 3</xref>, the proportion of patients needing mechanical ventilation was higher in the elderly group (71.4%) than that in the non-elderly group (50.0%). The incidence of acute kidney injury (AKI) was higher in the elderly group (50.0%) than that in the non-elderly group (33.3%) and the length of the hospital stay was 40 (19&#x2013;44) days in the elderly group and 25 (<xref ref-type="bibr" rid="B9">Esper et al., 2006</xref>; <xref ref-type="bibr" rid="B19">Mees et al., 2008</xref>; <xref ref-type="bibr" rid="B35">Turnbull et al., 2009</xref>; <xref ref-type="bibr" rid="B1">Alves-Filho et al., 2010</xref>; <xref ref-type="bibr" rid="B12">Gentile et al., 2012</xref>; <xref ref-type="bibr" rid="B25">Prakash et al., 2012</xref>; <xref ref-type="bibr" rid="B27">Sadaka et al., 2013</xref>; <xref ref-type="bibr" rid="B31">Shaw et al., 2013</xref>; <xref ref-type="bibr" rid="B6">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="B21">Nacionales et al., 2014</xref>; <xref ref-type="bibr" rid="B36">Vanzant et al., 2014</xref>; <xref ref-type="bibr" rid="B22">Nacionales et al., 2015</xref>; <xref ref-type="bibr" rid="B29">Shalova et al., 2015</xref>; <xref ref-type="bibr" rid="B32">Singer et al., 2016</xref>; <xref ref-type="bibr" rid="B20">Mira et al., 2017</xref>; <xref ref-type="bibr" rid="B15">Kumar, 2018</xref>; <xref ref-type="bibr" rid="B26">Raymond et al., 2018</xref>; <xref ref-type="bibr" rid="B38">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="B7">Coakley et al., 2019</xref>; <xref ref-type="bibr" rid="B14">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="B24">Peerapornratana et al., 2019</xref>; <xref ref-type="bibr" rid="B2">Bartsch et al., 2020</xref>; <xref ref-type="bibr" rid="B11">Gameiro et al., 2020</xref>; <xref ref-type="bibr" rid="B16">Levey et al., 2020</xref>; <xref ref-type="bibr" rid="B17">Mae et al., 2020</xref>; <xref ref-type="bibr" rid="B30">Shao et al., 2020</xref>; <xref ref-type="bibr" rid="B4">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="B39">Yu et al., 2021</xref>) days in the mostly non-elderly group. Additionally, the 90-day mortality rate was higher in the elderly group (28.6%) than that in the non-elderly group (16.7%), but no significant differences in these outcomes were observed (<italic>p</italic> &#x3e; 0.05). We also found that patients in the elderly group spent more time in the ICU [30 (11&#x2013;41) days] than those in the non-elderly group [21 (12&#x2013;42) days] (<italic>p</italic> &#x3c; 0.05).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Outcome measures in patients with abdominal sepsis in different age groups.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Outcome indicator</th>
<th align="left">Total (<italic>n</italic> &#x3d; 32)</th>
<th align="left">Group A (&#x2265;65; <italic>n</italic> &#x3d; 14)&#xa0;</th>
<th align="left">Group B (&#x3c;65; <italic>n</italic> &#x3d; 18)&#xa0;</th>
<th align="left">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">MV(%)</td>
<td align="left">19 (59.4)</td>
<td align="left">10 (71.4)</td>
<td align="left">9 (50.0)</td>
<td align="left">0.221</td>
</tr>
<tr>
<td align="left">AKI(%)</td>
<td align="left">13 (40.6)</td>
<td align="left">7 (50.0)</td>
<td align="left">6 (33.3)</td>
<td align="left">0.341</td>
</tr>
<tr>
<td align="left">RRT (%)</td>
<td align="left">10 (31.3)</td>
<td align="left">6 (42.9)</td>
<td align="left">4 (22.2)</td>
<td align="left">0.212</td>
</tr>
<tr>
<td align="left">Vasoactive agent (%)</td>
<td align="left">17 (53.1)</td>
<td align="left">10 (71.4)</td>
<td align="left">7 (38.9)</td>
<td align="left">0.087</td>
</tr>
<tr>
<td align="left">Superinfection (%)</td>
<td align="left">8 (25.0)</td>
<td align="left">4 (28.6)</td>
<td align="left">4 (22.2)</td>
<td align="left">0.681</td>
</tr>
<tr>
<td align="left">Length of stay (Day)</td>
<td align="left">32 (16&#x2013;42)</td>
<td align="left">40 (19&#x2013;44)</td>
<td align="left">25 (11&#x2013;38)</td>
<td align="left">0.224</td>
</tr>
<tr>
<td align="left">Days in the ICU (Day)</td>
<td align="left">13 (8&#x2013;36)</td>
<td align="left">30 (11&#x2013;41)</td>
<td align="left">21 (12&#x2013;42)</td>
<td align="left">0.045</td>
</tr>
<tr>
<td align="left">90-day mortality rate(%)</td>
<td align="left">7 (21.9)</td>
<td align="left">4 (28.6)</td>
<td align="left">3 (16.7)</td>
<td align="left">0.419</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: Group A indicates the cohort of patients aged &#x2265;65&#xa0;years. Group B indicates the cohort of patients aged &#x3c;65&#xa0;years. MV, mechanical ventilation; AKI, acute kidney injury; RRT, renal replacement therapy.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Poor physiological reserve, immune aging, pre-existing conditions, and previous antibiotic exposure in the elderly population all increase the risk of infection, and sepsis is common in the global elderly population. These risk factors partly reflect the increased morbidity and mortality due to infection and non-infectious inflammation seen in the elderly population (<xref ref-type="bibr" rid="B31">Shaw et al., 2013</xref>). Sepsis is a life-threatening imbalance of host responses to infection (<xref ref-type="bibr" rid="B32">Singer et al., 2016</xref>). Abdominal infection is a common occurrence following surgery and can lead to sepsis (<xref ref-type="bibr" rid="B18">Mazuski et al., 2017</xref>). Due to the increasing number of elderly people, it is important to study the impact of age on abdominal sepsis patient outcomes, especially in the context of rising socioeconomic and medical burdens (<xref ref-type="bibr" rid="B2">Bartsch et al., 2020</xref>). It is well-known that elderly patients have higher morbidity from abdominal sepsis than younger patients (<xref ref-type="bibr" rid="B4">Chen et al., 2021</xref>). In recent years, the mortality rate of abdominal sepsis has decreased with improvements in diagnosis and treatment technology, but the absolute number of deaths is still high because the number of clinical cases increasing, especially those elderly patients who eventually die of complications, including secondary superinfection, multiple organ dysfunction syndrome, septic shock, persistent inflammatory immunosuppression, and catabolic syndrome (<xref ref-type="bibr" rid="B12">Gentile et al., 2012</xref>; <xref ref-type="bibr" rid="B36">Vanzant et al., 2014</xref>).</p>
<p>In this study, the proportion of elderly patients with underlying diseases was higher than that of non-elderly patients, although the difference between the two was not statistically significant, which may be related to the relatively small sample size of this study. Common underlying diseases in the elderly population include coronary heart disease, congestive heart failure, chronic kidney disease, diabetes, chronic liver failure, chronic obstructive pulmonary disease, malignancies, and chronic infections (<xref ref-type="bibr" rid="B9">Esper et al., 2006</xref>). These complications can also mask and delay the diagnosis of sepsis and increase the risk of secondary infection. NLR is an inexpensive and readily available tool that has been shown to provide information on nonspecific systemic inflammation. It has been used to assess malignant tumors (<xref ref-type="bibr" rid="B14">Guo et al., 2019</xref>), sepsis (<xref ref-type="bibr" rid="B24">Peerapornratana et al., 2019</xref>), kidney diseases (<xref ref-type="bibr" rid="B17">Mae et al., 2020</xref>), and even Corona Virus disease 2019 (COVID-19) (<xref ref-type="bibr" rid="B39">Yu et al., 2021</xref>). Addition of neutrophil to lymphocyte and platelet ratio (NLPR) to NLR can further improve its clinical value (<xref ref-type="bibr" rid="B11">Gameiro et al., 2020</xref>; <xref ref-type="bibr" rid="B16">Levey et al., 2020</xref>). In this study, we analyzed clinical data from abdominal sepsis patients by age grouping to further explore the changes of NLR and NLPR. We found that NLRs and NLPRs were both significantly increased in elderly patients, especially NLRs, suggesting that NLRs may be more clinically valuable for elderly abdominal sepsis patients.</p>
<p>The association between NLPR and abdominal sepsis underscores the role of neutrophils, lymphocytes, and platelets in the development of sepsis. We found that the proportion of neutrophils in the elderly group was higher than that of the non-elderly group. A large number of activated neutrophils cannot normally migrate to the site of infection to play the role of eliminating pathogenic microorganisms, but can be transferred to various organs and systems of the body through blood circulation, resulting in corresponding tissue damage (<xref ref-type="bibr" rid="B26">Raymond et al., 2018</xref>; <xref ref-type="bibr" rid="B30">Shao et al., 2020</xref>). As the main part of adaptive immunity, lymphocytes play an important role in cellular and humoral immunity. Previous studies have found that in the pathogenesis of sepsis, T cell activation continues to fail, and the occurrence of sepsis is closely related to the failure of CD8<sup>&#x2b;</sup> helper T cell (Th)-1 and CD4<sup>&#x2b;</sup> Th17 lymphocytes (<xref ref-type="bibr" rid="B7">Coakley et al., 2019</xref>). At the same time, the up-regulated number of immunosuppressive regulatory T cells (Tregs) accelerates the apoptosis of lymphocytes (<xref ref-type="bibr" rid="B15">Kumar, 2018</xref>). Our study found that the lymphocyte count and proportion of elderly patients were lower than those of non-elderly patients, that is, elderly patients with abdominal sepsis were immunosuppressed. Platelets are important mediators that are abundant in the circulatory system and can rapidly release a variety of bioactive substances to regulate inflammation and hemostasis (<xref ref-type="bibr" rid="B11">Gameiro et al., 2020</xref>). Red blood cell distribution width (RDW) refers to the coefficient of variation of red blood cell volume. It has been suggested that an increase in admission RDW may be a predictor of short-term mortality in sepsis (<xref ref-type="bibr" rid="B27">Sadaka et al., 2013</xref>). In this study, elderly patients had significantly higher elevated RDWs and mortality rates than those in the non-elderly group. In the above studies on RDW and sepsis, the subjects were all adult sepsis patients (including elderly patients, aged &#x2265;65&#xa0;years), so some scholars considered the effect of age on the results of the study and studied the association between RDW and sepsis patients &#x3e;65. By studying the clinical data of elderly patients with severe sepsis and (or) septic shock, <xref ref-type="bibr" rid="B38">Wang et al. (2018)</xref> found that admission RDW was an independent predictor of in-hospital mortality in septic elderly patients.</p>
<p>Sepsis is currently recognized as causing widespread activation and dysfunction of the innate immune system (<xref ref-type="bibr" rid="B20">Mira et al., 2017</xref>). Neutrophils are an important part of the innate immune system of the human body and play an important role in resisting pathogen invasion and immune surveillance of infection. After the onset of sepsis, neutrophils accumulate in numerous sites of sepsis (<xref ref-type="bibr" rid="B1">Alves-Filho et al., 2010</xref>), which is beneficial in the early stages of sepsis and can kill pathogens. However, neutrophil <bold>regulation</bold> is complex in abdominal sepsis, and failure of neutrophil migration and shortened lifespan in severe sepsis have been well-established (<xref ref-type="bibr" rid="B25">Prakash et al., 2012</xref>). Therefore, as an important component of innate immunity, impaired neutrophil recruitment and migration are related to the pathogenesis and poor prognosis of sepsis. Monocytes play a role in both innate and adaptive immunity. When patients with sepsis are in a state of immunosuppression, the secretion of pro-inflammatory factors by monocytes decreases, while the secretion of anti-inflammatory factors increases, resulting in the phenomenon of &#x201c;endotoxin tolerance&#x201d; in which endotoxin phagocytosis is weakened (<xref ref-type="bibr" rid="B29">Shalova et al., 2015</xref>). Monocytes can also participate in adaptive immunity by acting as antigen-presenting cells to initiate T cell-specific differentiation.</p>
<p>Multiple aspects of innate immunity have been recently identified to be essential for the survival of sepsis, and this response is not clear in the elderly. In this study, we also found that the proportion of neutrophils and monocytes increased in patients with sepsis. We found that neutrophils increased more significantly in elderly patients and monocytes increased more significantly in non-elderly patients, but the proportion of neutrophils was significantly higher than monocytes. We observed that circulating phagocytes exhibit increased phagocytic function and bactericidal capacity, however neutrophils show decreased resting production of ROS while monocytes have increased oxidative stress. It was found that there was no difference in the level of lung injury between juvenile and aged mice after <italic>P. pneumoniae</italic> infection in a septic mouse model (<xref ref-type="bibr" rid="B22">Nacionales et al., 2015</xref>). However, bronchoalveolar lavage fluid samples after sepsis showed defective neutrophil function in aged animals. These defects were not found to include a decrease in ROS production though there was a significant decrease in leukocytes in the lungs after sepsis and pneumonia, indicating a defect in phagocyte recruitment in the elderly compared to the young (<xref ref-type="bibr" rid="B6">Chen et al., 2014</xref>). Phagocytosis analysis indicated that less phagocytic activity but more cells doing phagocytosis (though weak). In this study, monocytes in elderly septic patients have markedly increased release of ROS, providing evidence for an overwhelming nonspecific hyperinflammatory state in the early phase of sepsis, which leads to hypoperfusion and tissue damage in the early phase of sepsis. This further explains the reason for elderly patients requiring higher organ support conditions and with lower survival rates in abdominal sepsis. Clearly, patients with severe infections who develop multiple organ failure often suffer from immune dysfunction (<xref ref-type="bibr" rid="B21">Nacionales et al., 2014</xref>). It has been hypothesized that higher age exacerbates these immune impairments (<xref ref-type="bibr" rid="B19">Mees et al., 2008</xref>), but the mechanism remains unclear. After intraperitoneal sepsis, the cytokine response in aged mice was similar to that in young mice (<xref ref-type="bibr" rid="B35">Turnbull et al., 2009</xref>). This was also confirmed by our results, where we found that cytokines secreted by both neutrophils and monocytes increased after abdominal sepsis; after grouping by age, the ability of neutrophils to secrete cytokines was significantly enhanced in the elderly group, with little difference in monocytes between the elderly and non-elderly groups, but the proportion of neutrophils in whole blood cells was significantly higher than that in monocytes. It has been shown that during infection phagocyte function does not decline in all patients, especially during the development of organ failure, with increased production of proinflammatory cytokines (<xref ref-type="bibr" rid="B34">Taylor et al., 2014</xref>).</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>Patients classified as elderly are more likely to have underlying organ dysfunction, low immunity, etc., putting them at greater risk for developing sepsis and having long-term health deficits. In this context, our study focused on the effect of aging on the clinical sepsis characteristics and immune function. We found that elderly patients have decreased immune cell function and increased release of cytokines compared to younger patients, suggesting individualized treatment plans targeting the elderly septic microenvironment could help prevent organ failure in elderly septic patients and improve patient survival.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the Committee of Ethics at Beijing Ditan Hospital, Capital Medical University [Department of medical ethics; Beijing Ditan Hospital (2021)-005]. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>Conception and design: JQL and AL; Administrative support: AL; Provision of study materials or patients: JGL; Collection and assembly of data: LZ; Data analysis and interpretation: YZ; Manuscript writing: JQL; Final approval of manuscript: All authors.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves-Filho</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Spiller</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>F. Q.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Neutrophil paralysis in sepsis</article-title>. <source>Shock.</source> <volume>34</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1097/SHK.0b013e3181e7e61b</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartsch</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>McKinnell</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>O&#x27;Shea</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Wedlock</surname>
<given-names>P. T.</given-names>
</name>
<name>
<surname>Siegmund</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The potential health care costs and resource use associated with COVID-19 in the United States</article-title>. <source>Health Aff.</source> <volume>39</volume> (<issue>6</issue>), <fpage>927</fpage>&#x2013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1377/hlthaff.2020.00426</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carbajal-Guerrero</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cayuela-Dom&#xed;nguez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Garc&#xed;a</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Aldab&#xf3;-Pall&#xe1;s</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>M&#xe1;rquez-V&#xe1;caro</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Ortiz-Leyba</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Epidemiology and long-term outcome of sepsis in elderly patients</article-title>. <source>Med. Intensiva</source> <volume>38</volume> (<issue>1</issue>), <fpage>21</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.medin.2012.12.006</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X. F.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>High-flow hydrogen inhalation might suppresses the immune function of middle-aged participants: A self-controlled study</article-title>. <source>Med. Gas. Res.</source> <volume>11</volume> (<issue>1</issue>), <fpage>12</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.4103/2045-9912.310054</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Novel &#x3b2;-lactam/&#x3b2;-lactamase inhibitors versus alternative antibiotics for the treatment of complicated intra-abdominal infection and complicated urinary tract infection: A meta-analysis of randomized controlled trials</article-title>. <source>Expert Rev. anti. Infect. Ther.</source> <volume>16</volume> (<issue>2</issue>), <fpage>111</fpage>&#x2013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1080/14787210.2018.1429912</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Plackett</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Deburghgraeve</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>E. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Age-related differences in the neutrophil response to pulmonary pseudomonas infection</article-title>. <source>Exp. Gerontol.</source> <volume>54</volume>, <fpage>42</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2013.12.010</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coakley</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Breen</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Moreno-Olivera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Al-Harbi</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>O&#x27;Connell</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Dysregulated T helper type 1 (Th1) and Th17 responses in elderly hospitalised patients with infection and sepsis</article-title>. <source>PloS one</source> <volume>14</volume> (<issue>10</issue>), <fpage>e0224276</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0224276</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dombrovskiy</surname>
<given-names>V. Y.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Sunderram</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003</article-title>. <source>Crit. Care Med.</source> <volume>35</volume> (<issue>5</issue>), <fpage>1244</fpage>&#x2013;<lpage>1250</lpage>. <pub-id pub-id-type="doi">10.1097/01.CCM.0000261890.41311.E9</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esper</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Nisbet</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mannino</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The role of infection and comorbidity: Factors that influence disparities in sepsis</article-title>. <source>Crit. Care Med.</source> <volume>34</volume> (<issue>10</issue>), <fpage>2576</fpage>&#x2013;<lpage>2582</lpage>. <pub-id pub-id-type="doi">10.1097/01.CCM.0000239114.50519.0E</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>F&#xfc;l&#xf6;p</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Witkowski</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Larbi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The role of immunosenescence in the development of age-related diseases</article-title>. <source>Rev. Invest. Clin.</source> <volume>68</volume> (<issue>2</issue>), <fpage>84</fpage>&#x2013;<lpage>91</lpage>. </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gameiro</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Jorge</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gouveia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Neutrophil, lymphocyte and platelet ratio as a predictor of mortality in septic-acute kidney injury patients</article-title>. <source>Nefrologia</source> <volume>40</volume> (<issue>4</issue>), <fpage>461</fpage>&#x2013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1016/j.nefro.2019.11.006</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Cuenca</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Efron</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bihorac</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McKinley</surname>
<given-names>B. A.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care</article-title>. <source>J. Trauma Acute Care Surg.</source> <volume>72</volume> (<issue>6</issue>), <fpage>1491</fpage>&#x2013;<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1097/TA.0b013e318256e000</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girard</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Opal</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Ely</surname>
<given-names>E. W.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Insights into severe sepsis in older patients: From epidemiology to evidence-based management</article-title>. <source>Clin. Infect. Dis.</source> <volume>40</volume> (<issue>5</issue>), <fpage>719</fpage>&#x2013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1086/427876</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Incorporation of the SUVmax measured from FDG PET and neutrophil-to-lymphocyte ratio improves prediction of clinical outcomes in patients with locally advanced non-small-cell lung cancer</article-title>. <source>Clin. Lung Cancer</source> <volume>20</volume> (<issue>6</issue>), <fpage>412</fpage>&#x2013;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1016/j.cllc.2019.06.008</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>T cells and their immunometabolism: A novel way to understanding sepsis immunopathogenesis and future therapeutics</article-title>. <source>Eur. J. Cell. Biol.</source> <volume>97</volume> (<issue>6</issue>), <fpage>379</fpage>&#x2013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejcb.2018.05.001</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levey</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Eckardt</surname>
<given-names>K. U.</given-names>
</name>
<name>
<surname>Dorman</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Christiansen</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Hoorn</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Ingelfinger</surname>
<given-names>J. R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Nomenclature for kidney function and disease: Report of a kidney disease: Improving global outcomes (KDIGO) consensus conference</article-title>. <source>Kidney Int.</source> <volume>97</volume> (<issue>6</issue>), <fpage>1117</fpage>&#x2013;<lpage>1129</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2020.02.010</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mae</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for renal outcomes in patients with rapidly progressive glomerulonephritis</article-title>. <source>J. Clin. Med.</source> <volume>9</volume> (<issue>4</issue>), <fpage>E1128</fpage>. <pub-id pub-id-type="doi">10.3390/jcm9041128</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazuski</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Tessier</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Sawyer</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Nadler</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Rosengart</surname>
<given-names>M. R.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The surgical infection society revised guidelines on the management of intra-abdominal infection</article-title>. <source>Surg. Infect.</source> <volume>18</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1089/sur.2016.261</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mees</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Gwinner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marx</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Faendrich</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Haier</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Influence of sex and age on morphological organ damage after hemorrhagic shock</article-title>. <source>Shock (Augusta, Ga)</source> <volume>29</volume> (<issue>6</issue>), <fpage>670</fpage>&#x2013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1097/shk.0b013e31815c3ea0</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mira</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Brakenridge</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Moldawer</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>F. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Persistent inflammation, immunosuppression and catabolism syndrome</article-title>. <source>Crit. Care Clin.</source> <volume>33</volume> (<issue>2</issue>), <fpage>245</fpage>&#x2013;<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccc.2016.12.001</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nacionales</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Gentile</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Vanzant</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Cuenca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cuenca</surname>
<given-names>A. G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Aged mice are unable to mount an effective myeloid response to sepsis</article-title>. <source>J. Immunol.</source> <volume>192</volume> (<issue>2</issue>), <fpage>612</fpage>&#x2013;<lpage>622</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1302109</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nacionales</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Szpila</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ungaro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gentile</surname>
<given-names>L. F.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>A detailed characterization of the dysfunctional immunity and abnormal myelopoiesis induced by severe shock and trauma in the aged</article-title>. <source>J. Immunol.</source> <volume>195</volume> (<issue>5</issue>), <fpage>2396</fpage>&#x2013;<lpage>2407</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1500984</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Solak</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Turhan-Haktanir</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ay&#xe7;i&#xe7;ek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Demir</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ela</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>The prognostic importance of trauma scoring systems in pediatric patients</article-title>. <source>Pediatr. Surg. Int.</source> <volume>25</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s00383-008-2287-5</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peerapornratana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Manrique-Caballero</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>G&#xf3;mez</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kellum</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment</article-title>. <source>Kidney Int.</source> <volume>96</volume> (<issue>5</issue>), <fpage>1083</fpage>&#x2013;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2019.05.026</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prakash</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Lentsch</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Pritts</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>B. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Human microparticles generated during sepsis in patients with critical illness are neutrophil-derived and modulate the immune response</article-title>. <source>J. Trauma Acute Care Surg.</source> <volume>73</volume> (<issue>2</issue>), <fpage>401</fpage>&#x2013;<lpage>406</lpage>. <comment>discussion 6-7</comment>. <pub-id pub-id-type="doi">10.1097/TA.0b013e31825a776d</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raymond</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Stortz</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Ungaro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dirain</surname>
<given-names>M. L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Sepsis is associated with reduced spontaneous neutrophil migration velocity in human adults</article-title>. <source>PloS one</source> <volume>13</volume> (<issue>10</issue>), <fpage>e0205327</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0205327</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadaka</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>O&#x27;Brien</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Red cell distribution width and outcome in patients with septic shock</article-title>. <source>J. Intensive Care Med.</source> <volume>28</volume> (<issue>5</issue>), <fpage>307</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1177/0885066612452838</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadighi Akha</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Aging and the immune system: An overview</article-title>. <source>J. Immunol. Methods</source> <volume>463</volume>, <fpage>21</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.jim.2018.08.005</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shalova</surname>
<given-names>I. N.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Chittezhath</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zinkernagel</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Beasley</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-Jim&#xe9;nez</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1&#x3b1;</article-title>. <source>Immunity</source> <volume>42</volume> (<issue>3</issue>), <fpage>484</fpage>&#x2013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.02.001</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Cong</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The diagnostic roles of neutrophil in bloodstream infections</article-title>. <source>Immunobiology</source> <volume>225</volume> (<issue>1</issue>), <fpage>151858</fpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2019.10.007</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>R. R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Age-dependent dysregulation of innate immunity</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume> (<issue>12</issue>), <fpage>875</fpage>&#x2013;<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1038/nri3547</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Deutschman</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Seymour</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Shankar-Hari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Annane</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The third international consensus definitions for sepsis and septic shock (Sepsis-3)</article-title>. <source>Jama</source> <volume>315</volume> (<issue>8</issue>), <fpage>801</fpage>&#x2013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starr</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Sepsis in old age: Review of human and animal studies</article-title>. <source>Aging Dis.</source> <volume>5</volume> (<issue>2</issue>), <fpage>126</fpage>&#x2013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2014.0500126</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Manakkat Vijay</surname>
<given-names>G. K.</given-names>
</name>
<name>
<surname>Abeles</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Auzinger</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bernal</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality</article-title>. <source>Aliment. Pharmacol. Ther.</source> <volume>40</volume> (<issue>6</issue>), <fpage>705</fpage>&#x2013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1111/apt.12886</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbull</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Stromberg</surname>
<given-names>P. E.</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Woolsey</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>C. G.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Effects of aging on the immunopathologic response to sepsis</article-title>. <source>Crit. Care Med.</source> <volume>37</volume> (<issue>3</issue>), <fpage>1018</fpage>&#x2013;<lpage>1023</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0b013e3181968f3a</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanzant</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Ozrazgat-Baslanti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ungaro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cuenca</surname>
<given-names>A. G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma</article-title>. <source>J. Trauma Acute Care Surg.</source> <volume>76</volume> (<issue>1</issue>), <fpage>21</fpage>&#x2013;<lpage>29</lpage>. <comment>discussion 9-30</comment>. <pub-id pub-id-type="doi">10.1097/TA.0b013e3182ab1ab5</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Sakr</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Martin-Loeches</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Prevalence and outcomes of infection among patients in intensive care units in 2017</article-title>. <source>Jama</source> <volume>323</volume> (<issue>15</issue>), <fpage>1478</fpage>&#x2013;<lpage>1487</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2020.2717</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>W. F.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C. K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Red blood cell distribution width is associated with mortality in elderly patients with sepsis</article-title>. <source>Am. J. Emerg. Med.</source> <volume>36</volume> (<issue>6</issue>), <fpage>949</fpage>&#x2013;<lpage>953</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajem.2017.10.056</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G. Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S. Q.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Predictive value of neutrophil-to-lymphocyte ratio and other inflammatory indicators in estimating clinical severity of coronavirus disease</article-title>. <source>World J. Emerg. Med.</source> <volume>12</volume> (<issue>1</issue>), <fpage>79</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.5847/wjem.j.1920-8642.2021.01.014</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>